Melior Capital Management is a renowned Swiss company investor and advisory firm that is dedicated exclusively to the global life-science sector. Our primary focus is on providing funding to medtech, biotech, and pharmaceutical companies by utilizing our institutional-quality service and process to offer capital. At Melior, we aim to fund qualified innovative projects with proven management teams, promising data, robust IP, strong corporate governance, and significant commercial upside potential in the short to medium term.

What sets us apart is our ability to navigate and take advantage of the inherent risks in the life-science sector. Thanks to our established market presence and strong relationships with leading companies in MedTech, Biotech, and Pharmaceuticals, we can identify industry trends, source compelling opportunities, and patiently build unique businesses in a dynamic and evolving landscape. We actively work with our investee companies to assess and manage risk, develop and execute business and financing plans, and optimize exit strategies.

Our team's extensive experience and expertise enable us to provide a guiding influence in the complex life-science environment. We invest in experienced management teams with differentiated strategies to build profitable and sustainable businesses, ultimately strengthening the economy. Our commitment to governance and incentives ensures that shareholders and management share common objectives, driving optimal outcomes.

While Melior does not accept inquiries from the general public, we welcome professional intermediaries to reach out to us. Subscribe to our newsletter to stay updated with our new projects and latest developments